OUR TECHNOLOGY
LIQUID BIOPSY
A test done on a blood sample, to look for circulating tumour cells (CTC) or pieces of circulating tumour DNA (ctDNA) shed by cancer cells in the blood of a patient.
Liquid biopsy is a test done on a blood sample, to look for circulating tumour cells (CTC) or pieces of circulating tumour DNA (ctDNA) shed by cancer cells in the blood of a patient. Procedure is rather safe, simple, fast, and cost effective, which only involves the extraction of patients’ blood.
Why is Liquid Biopsy useful?
- Liquid biopsy is non-invasive
- Representing summation of spatial heterogeneity
- It is useful to detect cancer at an early stage
- It is also useful in monitoring the responses to treatment and help explain why some cancers are resistant to therapies
- It is the best option when tissue biopsy is non-accessible in some advanced cancers
- It is able to be repeated serially to monitor molecular changes in tumour
References
1. Lovly, C., Berger, M. & Vnencak-Jones, C. (2016). Circulating tumor DNA. My Cancer Genome.
2. National Cancer Institute (2017). Liquid biopsy: Using DNA in blood to detect, track, and treat cancer. National Cancer Institute.
3. Behjati, S., & Tarpey, P. S. (2013). What is next generation sequencing? Archives of Disease in Childhood. Education and Practice Edition, 98(6), 236–238.
4. The Tayside Centre for Genomic Analysis (2014). Fragment analysis.
5. MRC-Holland-MLPA- an introduction.
OUR TECHNOLOGY
LIQUID BIOPSY
A test done on a blood sample, to look for circulating tumour cells (CTC) or pieces of circulating tumour DNA (ctDNA) shed by cancer cells in the blood of a patient.
Liquid biopsy is a test done on a blood sample, to look for circulating tumour cells (CTC) or pieces of circulating tumour DNA (ctDNA) shed by cancer cells in the blood of a patient. Procedure is rather safe, simple, fast, and cost effective, which only involves the extraction of patients’ blood.
Why is Liquid Biopsy useful?
- Liquid biopsy is non-invasive
- Representing summation of spatial heterogeneity
- It is useful to detect cancer at an early stage
- It is also useful in monitoring the responses to treatment and help explain why some cancers are resistant to therapies
- It is the best option when tissue biopsy is non-accessible in some advanced cancers
- It is able to be repeated serially to monitor molecular changes in tumour
References
1. Lovly, C., Berger, M. & Vnencak-Jones, C. (2016). Circulating tumor DNA. My Cancer Genome.
2. National Cancer Institute (2017). Liquid biopsy: Using DNA in blood to detect, track, and treat cancer. National Cancer Institute.
3. Behjati, S., & Tarpey, P. S. (2013). What is next generation sequencing? Archives of Disease in Childhood. Education and Practice Edition, 98(6), 236–238.
4. The Tayside Centre for Genomic Analysis (2014). Fragment analysis.
5. MRC-Holland-MLPA- an introduction.